Quarterly report pursuant to Section 13 or 15(d)

Fair Value Measurements and Hierarchy (Tables)

v3.22.2.2
Fair Value Measurements and Hierarchy (Tables)
9 Months Ended
Sep. 30, 2022
Fair Value Measurements and Hierarchy  
Schedule of carrying amounts of financial instruments

    

Successor

    

September 30, 2022

    

December 31, 2021

Financial assets:

 

  

 

  

Cash

$

34,357,237

$

140,477,586

Restricted cash

 

1,003,307

 

356,286

Clinics fees and insurance receivables, net

 

1,049,253

 

1,090,104

Other receivables

 

2,736,184

 

726,903

Financial liabilities:

 

  

 

  

Accounts payable and accrued expenses

 

24,072,391

 

17,730,683

Warrants liabilities

 

7,996,432

 

11,382,826

Schedule of fair value hierarchy for financial liabilities

    

Level 1

    

Level 2

    

Level 3

    

Total

Warrant liability as of September 30, 2022

$

7,774,549

$

$

221,883

$

7,996,432

Warrant liability as of December 31, 2021

 

10,880,550

 

 

502,276

 

11,382,826

Summary of Level 3 inputs into option pricing model

The key Level 3 inputs into the option pricing model as of September 30, 2022 relating to the Private Placement Warrants to purchase Class A Common Stock were as follows:

Volatility

    

60.00

%

Risk-Free Interest rate

 

4.16

%

Exercise Price

$

11.50

Expected Term

 

4.2

Years

The key Level 3 inputs into the option pricing model as of December 31, 2021 relating to the Private Placement Warrants to purchase Class A Common Stock were as follows:

Volatility

    

60.00

%

Risk-Free Interest rate

 

1.26

%

Exercise Price

$

11.50

Expected Term

 

4.9

Years

Schedule of changes in the fair value

Successor

Predecessor

    

Nine Months Ended September

  

  

Nine Months Ended September

30, 2022

30, 2021

Beginning Balance of Private Warrant Liability

$

502,276

$

6,316,605

Mark-to-Market Adjustment for Stock Warrants

 

(280,393)

 

12,063,265

Ending Balance of Private Warrant Liability

$

221,883

$

18,379,870